Transarterial chemoembolization combined with apatinib with or without PD-1 inhibitors in BCLC stage C hepatocellular carcinoma: A multicenter retrospective studyWei-Li Xia, Hai-Liang Li, Gang Wu et al.|Frontiers in Oncology|2022Cited by 25
Plasma arginase-1 as a predictive marker for early transarterial chemoembolization refractoriness in unresectable hepatocellular carcinomaWei-Li Xia, Hai-Liang Li, Shi‐Jun Xu et al.|Frontiers in Oncology|2022Cited by 5